ADIPOQ and Hyperglycemia: If it can be proven that adiponectin is involved in the pathogenesis of neonatal hyperglycemia, it appears reasonable to consider inducing adiponectin production, e.g. by pharmacologic interventions, as a future treatment option for hyperglycemia in without the risk of hypoglycemic events that come along with the administration of insulin [3].